Sodium Hyaluronate-Based Products Market Report 2026

The sodium hyaluronate-based products market size has grown strongly in recent years. It will grow from $11.46 billion in 2025 to $12.6 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to limited availability of high-purity sodium hyaluronate, growing cosmetic and aesthetic procedures, rising prevalence of osteoarthritis, expansion of dermatology and ophthalmology clinics, reliance on traditional injectable formulations.

The sodium hyaluronate-based products market size is expected to see strong growth in the next few years. It will grow to $18.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to advancements in injectable and topical formulations, increasing e-commerce distribution channels, rising demand for minimally invasive procedures, development of combination therapies, expansion of global beauty and wellness markets. Major trends in the forecast period include rising demand for dermal fillers and viscosupplements, growing adoption of hyaluronic acid-based cosmetic products, increasing use in ophthalmology and joint pain management, expansion of home care and beauty salon applications, development of novel formulations like powders and nasal sprays.

The growing demand for cosmetic procedures is anticipated to drive the expansion of the sodium hyaluronate-based products market in the coming years. Cosmetic procedures are medical or non-medical treatments carried out to enhance, improve, or modify an individual’s physical appearance. The rising popularity of cosmetic procedures is largely driven by the influence of social media, which promotes evolving beauty standards and visual self-presentation, motivating individuals to pursue aesthetic enhancements that align with prevailing trends. Sodium hyaluronate-based products support cosmetic procedures by enhancing skin hydration, elasticity, and volume retention, making them well suited for injectable fillers as well as pre- and post-procedure skincare applications. For example, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional organization, approximately 1.6 million cosmetic surgical procedures were performed globally. In addition, 347,782 liposuction procedures were recorded, representing a 7% increase compared to 2022. Therefore, the increasing demand for cosmetic procedures is driving the growth of the sodium hyaluronate-based products market.

Major companies operating in the sodium hyaluronate-based products market are emphasizing the use of advanced technologies such as biotechnology to improve product effectiveness, support sustainable manufacturing practices, and meet rising consumer demand for natural and safe ingredients. Biotechnology involves the application of biological systems or living organisms to develop or produce products and enables the biosynthesis of sodium hyaluronate through controlled and efficient processes such as microbial fermentation or cell culture techniques. For instance, in January 2023, Ashland Inc., a US-based chemicals company supplying specialty ingredients for personal care and pharmaceutical applications, launched The Natural Line, a range of personal care ingredients focused on sustainability and transparency. Key offerings include Hyalurotech sodium hyaluronate, produced using biotechnology, which delivers skin hydration and plumping benefits. The range also features ingredients such as Puraloe aloe vera, orchid complex OS ester, refined shea butter, and American clary sage essential oil, all recognized for their skin-nourishing properties. Through this launch, Ashland aims to provide environmentally conscious consumers with natural, easily identifiable ingredients.

In August 2025, Ono Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, partnered with Seikagaku Corporation to jointly develop and commercialize Gel-One for the treatment of osteoarthritis in Japan. Through this partnership, the companies aim to accelerate late-stage clinical development, ensure timely manufacturing and regulatory approval, and broaden access to long-acting intra-articular hyaluronate therapy for osteoarthritis patients. Seikagaku Corporation is a Japan-based biotechnology company specializing in glycoscience-based pharmaceuticals and medical devices.

Major companies operating in the sodium hyaluronate-based products market are Contipro Pharma AS, LG Chem Ltd., Shiseido Ltd., Zimmer Biomet, Galderma SA, Kewpie Corporation, ASHLAND Inc., Merz Pharmaceuticals, Fidia Farmaceutici SpA, Anika Therapeutics Inc., Lifecore Biomedical LLC., Seikagaku Corporation, HTL Biotechnology, Meiji Seika Pharma Co. Ltd., Arshine Pharmaceutical Co. Limited., Sinoway Industrial Co. Ltd., Bohus BioTech AB, Ferring Pharmaceuticals BV, Shandong Topscience Biotech Co. Ltd., Shandong AWA Biopharm Co. Ltd., Acmedi Korea Co. Ltd.

North America was the largest region in the sodium hyaluronate-based products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sodium hyaluronate-based products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sodium hyaluronate-based products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the sodium hyaluronate-based products market by increasing the cost of imported raw materials and specialized equipment used in production. Segments such as injectable dermal fillers and ophthalmic injections are most affected, particularly in Asia-Pacific regions like China and India, which are key manufacturing hubs. This has led to higher production costs and price adjustments across regions. On the positive side, tariffs are encouraging domestic production, fostering innovation in alternative formulations, and strengthening local supply chains.

The sodium hyaluronate-based products market research report is one of a series of new reports that provides sodium hyaluronate-based products market statistics, including sodium hyaluronate-based products industry global market size, regional shares, competitors with a sodium hyaluronate-based products market share, detailed sodium hyaluronate-based products market segments, market trends and opportunities, and any further data you may need to thrive in the sodium hyaluronate-based products industry. This sodium hyaluronate-based products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sodium hyaluronate-based products are formulations that use sodium hyaluronate as the primary active ingredient. Sodium hyaluronate is the water-soluble salt form of hyaluronic acid, a naturally occurring compound in the human body that is well known for its moisture-retaining capacity and its role in lubricating tissues.

The main types of sodium hyaluronate-based products include topical forms, injectable forms, and other variants. Topical sodium hyaluronate products consist of skincare and eye-care formulations developed to provide deep hydration and enhance skin texture by efficiently retaining moisture. These products are available in different formulations such as liquids, gels, and powders. They are used across a range of applications, including dermatology, orthopedics, ophthalmology, cosmetics, and pain management. Distribution channels include online pharmacies, retail pharmacies, and hospital pharmacies, while end users comprise hospitals, clinics, home care providers, and beauty salons.

The sodium hyaluronate-based products market consists of sales of skin moisturizers, anti-aging serums, dermal fillers, ophthalmic eye drops, joint injections for osteoarthritis, wound healing gels, and mucosal hydration sprays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.